Global Drug Safety and Pharmacovigilance (PV) Software Market Size, Status and Forecast 2024-2031

Report ID: 919244 | Published Date: Sep 2024 | No. of Page: 98 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 On-Premises
        1.2.3 Cloud-Based
    1.3 Market by Application
        1.3.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pharma and Biotech Companies
        1.3.3 Contract Research Organizations (CROs)
        1.3.4 Business Process Outsourcing (BPO) Firms
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Perspective (2016-2027)
    2.2 Drug Safety and Pharmacovigilance (PV) Software Growth Trends by Regions
        2.2.1 Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Drug Safety and Pharmacovigilance (PV) Software Historic Market Share by Regions (2016-2021)
        2.2.3 Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Regions (2022-2027)
    2.3 Drug Safety and Pharmacovigilance (PV) Software Industry Dynamic
        2.3.1 Drug Safety and Pharmacovigilance (PV) Software Market Trends
        2.3.2 Drug Safety and Pharmacovigilance (PV) Software Market Drivers
        2.3.3 Drug Safety and Pharmacovigilance (PV) Software Market Challenges
        2.3.4 Drug Safety and Pharmacovigilance (PV) Software Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Revenue
        3.1.1 Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Revenue (2016-2021)
        3.1.2 Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Players (2016-2021)
    3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance (PV) Software Revenue
    3.4 Global Drug Safety and Pharmacovigilance (PV) Software Market Concentration Ratio
        3.4.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance (PV) Software Revenue in 2020
    3.5 Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Area Served
    3.6 Key Players Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service
    3.7 Date of Enter into Drug Safety and Pharmacovigilance (PV) Software Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety and Pharmacovigilance (PV) Software Breakdown Data by Type
    4.1 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Type (2016-2021)
    4.2 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2022-2027)

5 Drug Safety and Pharmacovigilance (PV) Software Breakdown Data by Application
    5.1 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size by Application (2016-2021)
    5.2 Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
    6.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
        6.2.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021)
        6.2.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027)
        6.2.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2027)
    6.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
        6.3.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021)
        6.3.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027)
        6.3.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2027)
    6.4 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
        6.4.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021)
        6.4.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
    7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
        7.2.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021)
        7.2.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027)
        7.2.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2027)
    7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
        7.3.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021)
        7.3.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027)
        7.3.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2027)
    7.4 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
        7.4.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021)
        7.4.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
    8.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
        8.2.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2027)
    8.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
        8.3.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2027)
    8.4 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region
        8.4.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
    9.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
        9.2.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021)
        9.2.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027)
        9.2.3 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2027)
    9.3 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
        9.3.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021)
        9.3.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027)
        9.3.3 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2027)
    9.4 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
        9.4.1 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021)
        9.4.2 Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size (2016-2027)
    10.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
        10.2.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2027)
    10.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
        10.3.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2027)
    10.4 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country
        10.4.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 ArisGlobal (US)
        11.1.1 ArisGlobal (US) Company Details
        11.1.2 ArisGlobal (US) Business Overview
        11.1.3 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.1.4 ArisGlobal (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.1.5 ArisGlobal (US) Recent Development
    11.2 Ennov Solutions Inc. (US)
        11.2.1 Ennov Solutions Inc. (US) Company Details
        11.2.2 Ennov Solutions Inc. (US) Business Overview
        11.2.3 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.2.4 Ennov Solutions Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.2.5 Ennov Solutions Inc. (US) Recent Development
    11.3 EXTEDO GmbH (US)
        11.3.1 EXTEDO GmbH (US) Company Details
        11.3.2 EXTEDO GmbH (US) Business Overview
        11.3.3 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.3.4 EXTEDO GmbH (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.3.5 EXTEDO GmbH (US) Recent Development
    11.4 Online Business Applications, Inc. (US)
        11.4.1 Online Business Applications, Inc. (US) Company Details
        11.4.2 Online Business Applications, Inc. (US) Business Overview
        11.4.3 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.4.4 Online Business Applications, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.4.5 Online Business Applications, Inc. (US) Recent Development
    11.5 Oracle Corporation (US)
        11.5.1 Oracle Corporation (US) Company Details
        11.5.2 Oracle Corporation (US) Business Overview
        11.5.3 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.5.4 Oracle Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.5.5 Oracle Corporation (US) Recent Development
    11.6 Sarjen Systems Pvt. Ltd (India)
        11.6.1 Sarjen Systems Pvt. Ltd (India) Company Details
        11.6.2 Sarjen Systems Pvt. Ltd (India) Business Overview
        11.6.3 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.6.4 Sarjen Systems Pvt. Ltd (India) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.6.5 Sarjen Systems Pvt. Ltd (India) Recent Development
    11.7 Sparta Systems, Inc. (US)
        11.7.1 Sparta Systems, Inc. (US) Company Details
        11.7.2 Sparta Systems, Inc. (US) Business Overview
        11.7.3 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.7.4 Sparta Systems, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.7.5 Sparta Systems, Inc. (US) Recent Development
    11.8 United BioSource Corporation (US)
        11.8.1 United BioSource Corporation (US) Company Details
        11.8.2 United BioSource Corporation (US) Business Overview
        11.8.3 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Introduction
        11.8.4 United BioSource Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
        11.8.5 United BioSource Corporation (US) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of On-Premises
    Table 3. Key Players of Cloud-Based
    Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Regions (2016-2021)
    Table 8. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Regions (2022-2027)
    Table 10. Drug Safety and Pharmacovigilance (PV) Software Market Trends
    Table 11. Drug Safety and Pharmacovigilance (PV) Software Market Drivers
    Table 12. Drug Safety and Pharmacovigilance (PV) Software Market Challenges
    Table 13. Drug Safety and Pharmacovigilance (PV) Software Market Restraints
    Table 14. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Players (2016-2021)
    Table 16. Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2020)
    Table 17. Ranking of Global Top Drug Safety and Pharmacovigilance (PV) Software Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Drug Safety and Pharmacovigilance (PV) Software Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Drug Safety and Pharmacovigilance (PV) Software Product Solution and Service
    Table 21. Date of Enter into Drug Safety and Pharmacovigilance (PV) Software Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2016-2021)
    Table 25. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2016-2021)
    Table 29. Global Drug Safety and Pharmacovigilance (PV) Software Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. ArisGlobal (US) Company Details
    Table 62. ArisGlobal (US) Business Overview
    Table 63. ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 64. ArisGlobal (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 65. ArisGlobal (US) Recent Development
    Table 66. Ennov Solutions Inc. (US) Company Details
    Table 67. Ennov Solutions Inc. (US) Business Overview
    Table 68. Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 69. Ennov Solutions Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 70. Ennov Solutions Inc. (US) Recent Development
    Table 71. EXTEDO GmbH (US) Company Details
    Table 72. EXTEDO GmbH (US) Business Overview
    Table 73. EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 74. EXTEDO GmbH (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 75. EXTEDO GmbH (US) Recent Development
    Table 76. Online Business Applications, Inc. (US) Company Details
    Table 77. Online Business Applications, Inc. (US) Business Overview
    Table 78. Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 79. Online Business Applications, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 80. Online Business Applications, Inc. (US) Recent Development
    Table 81. Oracle Corporation (US) Company Details
    Table 82. Oracle Corporation (US) Business Overview
    Table 83. Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 84. Oracle Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 85. Oracle Corporation (US) Recent Development
    Table 86. Sarjen Systems Pvt. Ltd (India) Company Details
    Table 87. Sarjen Systems Pvt. Ltd (India) Business Overview
    Table 88. Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 89. Sarjen Systems Pvt. Ltd (India) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 90. Sarjen Systems Pvt. Ltd (India) Recent Development
    Table 91. Sparta Systems, Inc. (US) Company Details
    Table 92. Sparta Systems, Inc. (US) Business Overview
    Table 93. Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product
    Table 94. Sparta Systems, Inc. (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 95. Sparta Systems, Inc. (US) Recent Development
    Table 96. United BioSource Corporation (US) Company Details
    Table 97. United BioSource Corporation (US) Business Overview
    Table 98. United BioSource Corporation (US) Revenue in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021) & (US$ Million)
    Table 99. United BioSource Corporation (US) Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Type: 2020 VS 2027
    Figure 2. On-Premises Features
    Figure 3. Cloud-Based Features
    Figure 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Application: 2020 VS 2027
    Figure 5. Pharma and Biotech Companies Case Studies
    Figure 6. Contract Research Organizations (CROs) Case Studies
    Figure 7. Business Process Outsourcing (BPO) Firms Case Studies
    Figure 8. Other Case Studies
    Figure 9. Drug Safety and Pharmacovigilance (PV) Software Report Years Considered
    Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Regions: 2020 VS 2027
    Figure 13. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Regions (2022-2027)
    Figure 14. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Players in 2020
    Figure 15. Global Top Drug Safety and Pharmacovigilance (PV) Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance (PV) Software as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance (PV) Software Revenue in 2020
    Figure 17. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2016-2021)
    Figure 18. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Type (2022-2027)
    Figure 19. North America Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Type (2016-2027)
    Figure 21. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Application (2016-2027)
    Figure 22. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
    Figure 23. United States Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Type (2016-2027)
    Figure 27. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Application (2016-2027)
    Figure 28. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
    Figure 29. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2016-2027)
    Figure 39. China Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Type (2016-2027)
    Figure 47. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Application (2016-2027)
    Figure 48. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
    Figure 49. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2016-2027)
    Figure 55. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Drug Safety and Pharmacovigilance (PV) Software Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. ArisGlobal (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 59. Ennov Solutions Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 60. EXTEDO GmbH (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 61. Online Business Applications, Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 62. Oracle Corporation (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 63. Sarjen Systems Pvt. Ltd (India) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 64. Sparta Systems, Inc. (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 65. United BioSource Corporation (US) Revenue Growth Rate in Drug Safety and Pharmacovigilance (PV) Software Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ArisGlobal (US)
Ennov Solutions Inc. (US)
EXTEDO GmbH (US)
Online Business Applications, Inc. (US)
Oracle Corporation (US)
Sarjen Systems Pvt. Ltd (India)
Sparta Systems, Inc. (US)
United BioSource Corporation (US)
Frequently Asked Questions
Drug Safety and Pharmacovigilance (PV) Software report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug Safety and Pharmacovigilance (PV) Software report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug Safety and Pharmacovigilance (PV) Software report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports